Researchers from across the biomedical research community met in October to discuss solutions to the 'irreproducibility epidemic', which has been re-emphasized by new data from Novartis and Sigma-Aldrich.
Enjoying our latest content?
Log in or create an account to continue
- Access the most recent journalism from Nature's award-winning team
- Explore the latest features & opinion covering groundbreaking research
or
Rights and permissions
About this article
Cite this article
Dolgin, E. Drug discoverers chart path to tackling data irreproducibility. Nat Rev Drug Discov 13, 875–876 (2014). https://doi.org/10.1038/nrd4488
Published:
Issue date:
DOI: https://doi.org/10.1038/nrd4488
This article is cited by
-
Tackling reproducibility in academic preclinical drug discovery
Nature Reviews Drug Discovery (2015)
